Dextrose 50% side effects by duration, gender and age - a phase IV clinical study of FDA data

< 1 month:

1. Hyperkalaemia (damage to or disease of the kidney)
2. Hypokalaemia (low potassium)
3. Septic shock (shock due to blood infection)

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

1. Anxiety
2. Blindness
3. Blood bicarbonate decreased
4. Blood magnesium decreased
5. Blood pressure decreased
6. Bradycardia (abnormally slow heart action)
7. Death
8. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
9. Drug administration error
10. Enteritis (inflammation of the small intestine)

female:

1. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
2. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
3. Abdominal discomfort
4. Anion gap increased
5. Anxiety
6. Blood bicarbonate decreased
7. Blood pressure decreased
8. Bradycardia (abnormally slow heart action)
9. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
10. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)

male:

1. Vomiting
2. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
3. Injection site vesicles (fluid- or air-filled cavity or sac at injection site)
4. Neoplasm malignant (cancer tumour)
5. Pneumonia
6. Renal tubular necrosis (death of kidney tubules)
7. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
8. Staphylococcus test positive
9. Urinary tract infection
10. Alanine aminotransferase increased

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

1. Anion gap increased

30-39:

1. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
2. Blood bicarbonate decreased
3. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
4. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

40-49:

1. Blood pressure decreased
2. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
3. Pain
4. Somnolence (a state of near-sleep, a strong desire for sleep)

50-59:

1. Anxiety
2. Blood magnesium decreased

60+:

1. Bradycardia (abnormally slow heart action)
2. Drug administration error
3. Hyperkalaemia (damage to or disease of the kidney)
4. Injection site vesicles (fluid- or air-filled cavity or sac at injection site)
5. Neoplasm malignant (cancer tumour)
6. Pneumonia
7. Renal tubular necrosis (death of kidney tubules)
8. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
9. Staphylococcus test positive
10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)